Inflection Point Ventures (IPV), an angel investment network, launched IPV International on Thursday, a $110 million Category I Angel Fund registered with the International Financial Services Centres Authority (IFSCA) in GIFT City, Gujarat. It has obtained the Fund Registration Certificate and the Fund Management Entity (FME) license.
Key Highlights
- IPV launched a $110 million Category I Angel Fund under GIFT City, including $6 million greenshoe option.
- The fund targets early‑stage startups worldwide, striving to back approximately 60 companies annually under its corpus.
IPV International completed its first close in April 2025 and has already made its debut investment in Singapore-based deeptech startup Cellivate Technologies, which is developing a patented, ethical alternative to fetal bovine serum through magnetic stimulation, with applications in biotechnology and pharmaceuticals.
The sector-agnostic fund will invest in early-stage to pre-Series A startups across industries, with ticket sizes ranging from $100,000 to $1 million.
Vinay Bansal, Founder and CEO of IPV, stated, "A presence in GIFT City allows us to scale beyond national borders, engage with global startup ecosystems, and stay aligned with the rapidly changing dynamics of the venture capital and private equity markets."
"At the same time, we are seeing strong interest not only from Indians and NRIs, but also from non-Indian investors looking to invest in the thriving Indian startup ecosystem, and the GIFT City structure makes it significantly easier for them to do so," he added.
Also Read: Confluent Announces $200 Mn Investment Across Its Global Partner Ecosystem
Global and Indian participants, including NRIs, OCIs, and foreign nationals, who invest through GIFT City are exempt from filing Indian tax returns as long as their Indian-sourced income is limited to these investments. Meanwhile, resident Indian investors benefit from a simplified structure that avoids the complex approvals typically required under ODI or SEBI regulations.
Ankur Mittal, IPV's co-founder, stated, "This strategic move allows us to consider high-potential foreign startups alongside domestic opportunities." We are now well-positioned to invest in innovative ventures across international markets, enhancing both portfolio diversification and investor value, thanks to the GIFT City platform's global access.
Aside from IPV International, IPV manages Physis Capital, a $50 million Category II Venture Capital fund that supports pre-Series A to Series B startups. The fund has supported six startups, with several more in the works.
.jpg)